top of page
Search
Aug 11, 2022
Think Ahead, Be Prepared – TGA Post-market Review
Recently, the Therapeutic Goods Administration (TGA) cancelled the registration of four COVID-19 rapid antigen tests...
May 31, 2022
FDA Update: Risk Management and Preventing Drug Shortages
On 20 May 2022, the FDA issued a draft guidance concerning the role of risk management in the prevention of potential drug shortages...
May 18, 2022
TGA Follows FDA - COVID-19 Treatment Use Expanded
On 6 May 2022, the Therapeutic Goods Administration (TGA) provisionally approved the expanded use of Veklury (remdesivir) in Australia....
Top of page
bottom of page